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Background
Parkinson’s disease is a neurodegenerative disease affect-
ing at least 1% of the population over age of 55. It is char-
acterized by selective loss of dopaminergic neurons in
substantia nigra pars compacta and the appearance of
intracellular inclusions termed Lewy bodies. As the age
progresses, neurons in the other regions of brain are also
degenerated. Depletion of brain dopamine initiates
aberrant motor activities including rest tremor, rigidity,
bradykinesia, postural instability. Apart from motor
symptoms, cognitive impairments, like depression,
psychiatric illness, and decreased mental ability are also
observed in the patients. Genetic and non-genetic com-
ponents are believed to govern the pathogenesis of PD.
Genes in dopaminergic pathway & also dopamine synth-
esis, storage, binding, metabolism are needed to be
studied which seem to be major determinants conferring
differential risk of developing PD.
Methods
In this study, three reported SNPs, rs1611115 (T>C),
rs1108580 (A>G), rs129882 (C>T) of DBH have been
analyzed. For rs1611115 (T>C), 229 patients & 252 con-
trols have been screened. A total of 298 patients & 276
control samples have been analyzed for rs129882 (C>T).
A total of 378 patients & 253 control samples have been
analyzed for rs 1108580 (A>G). All these SNPs were
screened by PCR , sequencing and/or RFLP analysis.
Also, DBH activity has been measured in plasma isolated
from patients’ blood.
Results
For rs1611115 (T>C), the minor allele T is over repre-
sented in control samples & pose a protection (p=0.043,
OR=0.731, 95% CI=0.731 (0.538-0.847) for this disease.
No significant association has been found for rs1108580
(A>G). For rs129882 (C>T), the minor allele T is over
represented in patient pool & confers a risk (p=0.036,
OR=1.322, 95% CI=1.012-1.727) for this disease. DBH
activity has been measured in plasma isolated from
patients’ blood. A correlation has been found between
plasma DBH activity & rs1611115.
Conclusion
This study suggests that DBH might have a role in
susceptibility of developing Parkinson’s disease.
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